Oral Vaccine Offers Modern Hope in the Fight Against Colorectal Cancer A groundbreaking new approach to colorectal cancer treatment is emerging from Stony Brook University, offering a potential lifeline for patients who don’t respond to traditional immunotherapies. Researchers have developed an oral vaccine, built upon a modified strain of the bacterium Listeria monocytogenes, designed to … Read more
The Shadow Pandemic: AI, Fraud and the Future of Cancer Research The integrity of medical research is facing a growing threat, as a modern study reveals nearly 10% of cancer research papers show signs of fabrication by “paper mills” – organizations that sell manuscripts at an industrial scale. This alarming trend, highlighted in a recent … Read more
Rising Rejection of Vitamin K Shots: A Growing Threat to Newborn Brain Health? A concerning trend is emerging: more parents are declining the standard vitamin K injection for their newborns, despite overwhelming medical evidence supporting its safety and effectiveness. This decision, whereas rooted in various concerns, significantly increases the risk of potentially devastating and often … Read more
The Looming Threat of Measles: A Rare, Devastating Brain Condition is Making a Comeback Measles, often considered a childhood illness, carries a hidden and terrifying risk: long-term brain damage. Even as most recover, a rare but universally fatal condition called subacute sclerosing panencephalitis (SSPE) can develop years after the initial infection. Recent cases, and a … Read more
North Dakota’s Measles Resurgence: A Warning Sign for the Nation For generations, measles was a fading memory in North Dakota, a testament to the power of modern medicine. But a concerning trend is reversing that progress. A growing number of vaccine exemptions, fueled by misinformation, is leading to outbreaks and putting communities at risk. The … Read more
The Future of Pandemic Preparedness: Lessons from COVID-19 The COVID-19 pandemic exposed critical vulnerabilities in global health security. A recent article in The Lancet, authored by Lurie, Keusch, and Dzau, underscores the urgent need for a standing, coordinated system and sustainable financing for global research and development (R&D). While rapid vaccine development – exemplified by … Read more
FDA Reversal Paves the Way for Moderna’s mRNA Flu Vaccine The US Food and Drug Administration (FDA) has reversed its initial decision and will now review Moderna’s application for its innovative messenger RNA (mRNA)-based flu vaccine. This dramatic shift comes after a contentious back-and-forth with the pharmaceutical company, initially sparked by concerns over the clinical … Read more
Vaccine Mandates Face Legal Scrutiny: A Deep Dive into the AAP Lawsuit A federal judge, Brian E. Murphy of the District of Massachusetts, heard arguments this week in a significant lawsuit challenging recent changes to the U.S. Childhood vaccine schedule and the advisory committee that recommends them. The case, brought by the American Academy of … Read more
FDA’s Shocking Rejection of Moderna’s Flu Vaccine: A Turning Point for mRNA Technology? The Food and Drug Administration’s (FDA) decision to refuse review of Moderna’s mRNA-based flu vaccine application has sent shockwaves through the pharmaceutical industry. Moderna President Stephen Hoge described the move as “completely shocking,” raising questions about the future of mRNA vaccine development … Read more
Independent Vaccine Review: A New Era for Public Health? The American Medical Association (AMA) and the Vaccine Integrity Project at the University of Minnesota have joined forces to establish an independent system for reviewing vaccine safety and effectiveness. This move comes amid growing concerns about the Centers for Disease Control and Prevention’s (CDC) vaccine review … Read more